search

1-20 of 155

Save search

Sort by

Sort Order Select

2 3 4 5

Journal Article

10000- ET-1 STEM CELL-BASED GENE THERAPY FOR MALIGNANT GLIOMA USING GENOME-EDITED HUMAN INDUCED PLURIPOTENT STEM CELLS

PDF

Ryota Tamura and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Page iv4, https://doi.org/10.1093/noajnl/vdae173.014

Published: 29 November 2024

Journal Article

10112- ET-10 EVALUATING PBC-IP AS A NOVEL BORON CARRIER IN BNCT

PDF

Shinji Kawabata and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Page iv5, https://doi.org/10.1093/noajnl/vdae173.019

Published: 29 November 2024

Journal Article

10082- ET-9 ANTITUMOR AROMA THERAPY WITH FRANKINCENSE ESSENTIAL OIL FOR GLIOBLASTOMA

PDF

Norihiko Saito and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Page iv5, https://doi.org/10.1093/noajnl/vdae173.018

Published: 29 November 2024

Journal Article

10025- ET-3 IDENTIFICATION OF A NEW MOLECULAR TARGET FOR MESENCHYMAL GLIOBLASTOMA AND ITS FUNCTION

PDF

Kohei Miyazono and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Page iv5, https://doi.org/10.1093/noajnl/vdae173.016

Published: 29 November 2024

Journal Article

10065- ET-6 MRNA-ENCAPSULATED LIPID NANOPARTICLES FOR MALIGNANT GLIOMA

PDF

Takeshi Hiu and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Page iv5, https://doi.org/10.1093/noajnl/vdae173.017

Published: 29 November 2024

Journal Article

10199- ET-16 NEAR-INFRARED PHOTOIMMUNOTHERAPY FOR THE TREATMENT OF MALIGNANT BRAIN TUMORS

PDF

Manabu Natsumeda and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Pages iv5–iv6, https://doi.org/10.1093/noajnl/vdae173.020

Published: 29 November 2024

Journal Article

10022- ET-2 DEVELOPMENT OF MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY FOR IN SITU DIFFERENTIATION OF BRAIN TUMORS DURING MICROSURGERY

PDF

Taketo Ezaki and others

in Neuro-Oncology Advances

Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Pages iv4–iv5, https://doi.org/10.1093/noajnl/vdae173.015

Published: 29 November 2024

Journal Article

EXTH-50. THIOREDOXIN REDUCTASE1 AND MGMT SYNTHETIC LETHALITY ENHANCES CYTOTOXICITY OF PRIMA-1MET(APR-246) AND AURANOFIN IN GLIOBLASTOMA

PDF

Rehka Raveendrakumar and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi93, https://doi.org/10.1093/neuonc/noz175.381

Published: 11 November 2019

Journal Article

EXTH-08. REPLACEMENT OF MICROGLIA BY BRAIN-ENGRAFTED MACROPHAGES PREVENTS MEMORY DEFICITS AFTER THERAPEUTIC WHOLE-BRAIN IRRADIATION

PDF

Xi Feng and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi83–vi84, https://doi.org/10.1093/neuonc/noz175.342

Published: 11 November 2019

Journal Article

EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

PDF

Michael Ruff and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi88–vi89, https://doi.org/10.1093/neuonc/noz175.364

Published: 11 November 2019

Journal Article

EXTH-53. TUMOR TREATING FIELDS LEADS TO CHANGES IN MEMBRANE PERMEABILITY AND INCREASED PENETRATION BY ANTI-GLIOMA DRUGS

PDF

Edwin Chang and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi93, https://doi.org/10.1093/neuonc/noz175.384

Published: 11 November 2019

Journal Article

EXTH-71. IND-ENABLING CHARACTERIZATION OF ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR NEURO-ONCOLOGY

PDF

Varun Prabhu and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi97, https://doi.org/10.1093/neuonc/noz175.401

Published: 11 November 2019

Journal Article

EXTH-72. MANZAMINE A-DERIVED COMPOUNDS AS POTENTIAL ANTI-BRAIN TUMOR AGENTS AND IT MECHANISM STUDY

PDF

Chiung-Yin Huang and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi97, https://doi.org/10.1093/neuonc/noz175.402

Published: 11 November 2019

Journal Article

EXTH-34. IN VITRO TUMOR TREATING FIELDS (TTFIELDS) APPLIED PRIOR TO RADIATION ENHANCES THE RESPONSE TO RADIATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES

PDF

Sharon Michelhaugh and Sandeep Mittal

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi89, https://doi.org/10.1093/neuonc/noz175.366

Published: 11 November 2019

Journal Article

EXTH-10. THE ACTIVATION AND SENSITIZATION OF GLIOBLASTOMA CELLS VIA COLD ATMOSPHERIC PLASMA TREATMENT

PDF

Jonathan Sherman and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi84, https://doi.org/10.1093/neuonc/noz175.344

Published: 11 November 2019

Journal Article

EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS

PDF

Christopher Jackson and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi94, https://doi.org/10.1093/neuonc/noz175.386

Published: 11 November 2019

Journal Article

EXTH-20. HYPERPOLARIZED [2-¹³C] PYRUVATE TO [5-¹³C] GLUTAMATE AS BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO TEMOZOLOMIDE THERAPY

PDF

Elavarasan Subramani and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi86, https://doi.org/10.1093/neuonc/noz175.354

Published: 11 November 2019

Journal Article

EXTH-03. TRIPTOLIDE, A NOVEL THERAPEUTIC AGENT FOR IDH1-MUTATED GLIOMA

PDF

Di Yu and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi82–vi83, https://doi.org/10.1093/neuonc/noz175.337

Published: 11 November 2019

Journal Article

EXTH-67. IDENTIFICATION AND DEVELOPMENT OF NEURAL ECM-BINDING LAMPREY ANTIBODIES (VARIABLE LYMPHOCYTE RECEPTORS) THAT TARGET GLIOBLASTOMA

PDF

Benjamin Umlauf and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi96, https://doi.org/10.1093/neuonc/noz175.397

Published: 11 November 2019

Journal Article

EXTH-22. ENHANCED DRUG DELIVERY AND CIRCULATION WITH THE NEURAPHERESIS™ SYSTEM FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES

PDF

Choiselle Marius and others

in Neuro-Oncology

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi86–vi87, https://doi.org/10.1093/neuonc/noz175.356

Published: 11 November 2019

2 3 4 5

Modify your search

Availability

NARROW

Format

Type

Journal

Section

Publication date

10000- ET-1 STEM CELL-BASED GENE THERAPY FOR MALIGNANT GLIOMA USING GENOME-EDITED HUMAN INDUCED PLURIPOTENT STEM CELLS

10112- ET-10 EVALUATING PBC-IP AS A NOVEL BORON CARRIER IN BNCT

10082- ET-9 ANTITUMOR AROMA THERAPY WITH FRANKINCENSE ESSENTIAL OIL FOR GLIOBLASTOMA

10025- ET-3 IDENTIFICATION OF A NEW MOLECULAR TARGET FOR MESENCHYMAL GLIOBLASTOMA AND ITS FUNCTION

10065- ET-6 MRNA-ENCAPSULATED LIPID NANOPARTICLES FOR MALIGNANT GLIOMA

10199- ET-16 NEAR-INFRARED PHOTOIMMUNOTHERAPY FOR THE TREATMENT OF MALIGNANT BRAIN TUMORS

10022- ET-2 DEVELOPMENT OF MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY FOR IN SITU DIFFERENTIATION OF BRAIN TUMORS DURING MICROSURGERY

EXTH-50. THIOREDOXIN REDUCTASE1 AND MGMT SYNTHETIC LETHALITY ENHANCES CYTOTOXICITY OF PRIMA-1MET(APR-246) AND AURANOFIN IN GLIOBLASTOMA

EXTH-08. REPLACEMENT OF MICROGLIA BY BRAIN-ENGRAFTED MACROPHAGES PREVENTS MEMORY DEFICITS AFTER THERAPEUTIC WHOLE-BRAIN IRRADIATION

EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

EXTH-53. TUMOR TREATING FIELDS LEADS TO CHANGES IN MEMBRANE PERMEABILITY AND INCREASED PENETRATION BY ANTI-GLIOMA DRUGS

EXTH-71. IND-ENABLING CHARACTERIZATION OF ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR NEURO-ONCOLOGY

EXTH-72. MANZAMINE A-DERIVED COMPOUNDS AS POTENTIAL ANTI-BRAIN TUMOR AGENTS AND IT MECHANISM STUDY

EXTH-34. IN VITRO TUMOR TREATING FIELDS (TTFIELDS) APPLIED PRIOR TO RADIATION ENHANCES THE RESPONSE TO RADIATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES

EXTH-10. THE ACTIVATION AND SENSITIZATION OF GLIOBLASTOMA CELLS VIA COLD ATMOSPHERIC PLASMA TREATMENT

EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS

EXTH-20. HYPERPOLARIZED [2-¹³C] PYRUVATE TO [5-¹³C] GLUTAMATE AS BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO TEMOZOLOMIDE THERAPY

EXTH-03. TRIPTOLIDE, A NOVEL THERAPEUTIC AGENT FOR IDH1-MUTATED GLIOMA

EXTH-67. IDENTIFICATION AND DEVELOPMENT OF NEURAL ECM-BINDING LAMPREY ANTIBODIES (VARIABLE LYMPHOCYTE RECEPTORS) THAT TARGET GLIOBLASTOMA

EXTH-22. ENHANCED DRUG DELIVERY AND CIRCULATION WITH THE NEURAPHERESIS™ SYSTEM FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES

Modify your search

Publication date

10000- ET-1 STEM CELL-BASED GENE THERAPY FOR MALIGNANT GLIOMA USING GENOME-EDITED HUMAN INDUCED PLURIPOTENT STEM CELLS Open Access

10112- ET-10 EVALUATING PBC-IP AS A NOVEL BORON CARRIER IN BNCT Open Access

10082- ET-9 ANTITUMOR AROMA THERAPY WITH FRANKINCENSE ESSENTIAL OIL FOR GLIOBLASTOMA Open Access

10025- ET-3 IDENTIFICATION OF A NEW MOLECULAR TARGET FOR MESENCHYMAL GLIOBLASTOMA AND ITS FUNCTION Open Access

10065- ET-6 MRNA-ENCAPSULATED LIPID NANOPARTICLES FOR MALIGNANT GLIOMA Open Access

10199- ET-16 NEAR-INFRARED PHOTOIMMUNOTHERAPY FOR THE TREATMENT OF MALIGNANT BRAIN TUMORS Open Access

10022- ET-2 DEVELOPMENT OF MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY FOR IN SITU DIFFERENTIATION OF BRAIN TUMORS DURING MICROSURGERY Open Access

EXTH-50. THIOREDOXIN REDUCTASE1 AND MGMT SYNTHETIC LETHALITY ENHANCES CYTOTOXICITY OF PRIMA-1MET(APR-246) AND AURANOFIN IN GLIOBLASTOMA Free

EXTH-08. REPLACEMENT OF MICROGLIA BY BRAIN-ENGRAFTED MACROPHAGES PREVENTS MEMORY DEFICITS AFTER THERAPEUTIC WHOLE-BRAIN IRRADIATION Free

EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME Free

EXTH-53. TUMOR TREATING FIELDS LEADS TO CHANGES IN MEMBRANE PERMEABILITY AND INCREASED PENETRATION BY ANTI-GLIOMA DRUGS Free

EXTH-71. IND-ENABLING CHARACTERIZATION OF ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR NEURO-ONCOLOGY Free

EXTH-72. MANZAMINE A-DERIVED COMPOUNDS AS POTENTIAL ANTI-BRAIN TUMOR AGENTS AND IT MECHANISM STUDY Free

EXTH-34. IN VITRO TUMOR TREATING FIELDS (TTFIELDS) APPLIED PRIOR TO RADIATION ENHANCES THE RESPONSE TO RADIATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES Free

EXTH-10. THE ACTIVATION AND SENSITIZATION OF GLIOBLASTOMA CELLS VIA COLD ATMOSPHERIC PLASMA TREATMENT Free

EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS Free

EXTH-20. HYPERPOLARIZED [2-13C] PYRUVATE TO [5-13C] GLUTAMATE AS BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO TEMOZOLOMIDE THERAPY Free

EXTH-03. TRIPTOLIDE, A NOVEL THERAPEUTIC AGENT FOR IDH1-MUTATED GLIOMA Free

EXTH-67. IDENTIFICATION AND DEVELOPMENT OF NEURAL ECM-BINDING LAMPREY ANTIBODIES (VARIABLE LYMPHOCYTE RECEPTORS) THAT TARGET GLIOBLASTOMA Free

EXTH-22. ENHANCED DRUG DELIVERY AND CIRCULATION WITH THE NEURAPHERESIS™ SYSTEM FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES Free

This Feature Is Available To Subscribers Only

10000- ET-1 STEM CELL-BASED GENE THERAPY FOR MALIGNANT GLIOMA USING GENOME-EDITED HUMAN INDUCED PLURIPOTENT STEM CELLS

10112- ET-10 EVALUATING PBC-IP AS A NOVEL BORON CARRIER IN BNCT

10082- ET-9 ANTITUMOR AROMA THERAPY WITH FRANKINCENSE ESSENTIAL OIL FOR GLIOBLASTOMA

10025- ET-3 IDENTIFICATION OF A NEW MOLECULAR TARGET FOR MESENCHYMAL GLIOBLASTOMA AND ITS FUNCTION

10065- ET-6 MRNA-ENCAPSULATED LIPID NANOPARTICLES FOR MALIGNANT GLIOMA

10199- ET-16 NEAR-INFRARED PHOTOIMMUNOTHERAPY FOR THE TREATMENT OF MALIGNANT BRAIN TUMORS

10022- ET-2 DEVELOPMENT OF MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY FOR IN SITU DIFFERENTIATION OF BRAIN TUMORS DURING MICROSURGERY

EXTH-50. THIOREDOXIN REDUCTASE1 AND MGMT SYNTHETIC LETHALITY ENHANCES CYTOTOXICITY OF PRIMA-1MET(APR-246) AND AURANOFIN IN GLIOBLASTOMA

EXTH-08. REPLACEMENT OF MICROGLIA BY BRAIN-ENGRAFTED MACROPHAGES PREVENTS MEMORY DEFICITS AFTER THERAPEUTIC WHOLE-BRAIN IRRADIATION

EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

EXTH-53. TUMOR TREATING FIELDS LEADS TO CHANGES IN MEMBRANE PERMEABILITY AND INCREASED PENETRATION BY ANTI-GLIOMA DRUGS

EXTH-71. IND-ENABLING CHARACTERIZATION OF ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR NEURO-ONCOLOGY

EXTH-72. MANZAMINE A-DERIVED COMPOUNDS AS POTENTIAL ANTI-BRAIN TUMOR AGENTS AND IT MECHANISM STUDY

EXTH-34. IN VITRO TUMOR TREATING FIELDS (TTFIELDS) APPLIED PRIOR TO RADIATION ENHANCES THE RESPONSE TO RADIATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES

EXTH-10. THE ACTIVATION AND SENSITIZATION OF GLIOBLASTOMA CELLS VIA COLD ATMOSPHERIC PLASMA TREATMENT

EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS

EXTH-20. HYPERPOLARIZED [2-¹³C] PYRUVATE TO [5-¹³C] GLUTAMATE AS BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO TEMOZOLOMIDE THERAPY

EXTH-03. TRIPTOLIDE, A NOVEL THERAPEUTIC AGENT FOR IDH1-MUTATED GLIOMA

EXTH-67. IDENTIFICATION AND DEVELOPMENT OF NEURAL ECM-BINDING LAMPREY ANTIBODIES (VARIABLE LYMPHOCYTE RECEPTORS) THAT TARGET GLIOBLASTOMA

EXTH-22. ENHANCED DRUG DELIVERY AND CIRCULATION WITH THE NEURAPHERESIS™ SYSTEM FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES